Jason Taylor

We actually work really, really hard as Canadians to try to maintain that facade that we are all very nice and we apologize a lot. But I think inside, a lot of us have that more American core that we want the opportunity to get out and be aggressive and be a little less nice. But we don't get to explore it at home. We end up apologizing more often than not.

We actually work really, really hard as Canadians to try to maintain that facade that we are all very nice and we apologize a lot. But I think inside, a lot of us have that more American core that we want the opportunity to get out and be aggressive and be a little less nice. But we don't get to explore it at home. We end up apologizing more often than not.

So I think this year, that's a more relevant discussion than anything, Scott. We've had with the new administration coming in in Washington, we've had some new policy initiatives that have been, I'll say, partially introduced. I think that's creating a lot of tension in the system for health care providers. So we could be fans of what the Trump administration is doing or we could be opposed to it.

So I think this year, that's a more relevant discussion than anything, Scott. We've had with the new administration coming in in Washington, we've had some new policy initiatives that have been, I'll say, partially introduced. I think that's creating a lot of tension in the system for health care providers. So we could be fans of what the Trump administration is doing or we could be opposed to it.

What matters right now is there's a lot of uncertainty. And this comes at a pivotal time in investment in tech for a lot of healthcare systems. So as you know, because you spent a lot of time in this, there's roughly 400 health systems in the country. There's another 400 or so standalone hospitals that act independently.

What matters right now is there's a lot of uncertainty. And this comes at a pivotal time in investment in tech for a lot of healthcare systems. So as you know, because you spent a lot of time in this, there's roughly 400 health systems in the country. There's another 400 or so standalone hospitals that act independently.

And then there's 1,200 kind of critical access safety net systems that are mostly rural but spread out across the country. So this is a fairly small community. But even within that community, we spend a lot of time talking about the big 30 or 40 systems, the Mayo Clinics, the Cleveland Clinics, Johns Hopkins, kind of big name firms that deliver health care.

And then there's 1,200 kind of critical access safety net systems that are mostly rural but spread out across the country. So this is a fairly small community. But even within that community, we spend a lot of time talking about the big 30 or 40 systems, the Mayo Clinics, the Cleveland Clinics, Johns Hopkins, kind of big name firms that deliver health care.

What we don't spend a lot of time on is that the bottom 90% of these health systems and large hospitals are fairly resource strapped. They don't have big teams. They don't have big budgets. And so when change happens, even if it's positive innovation change, they don't have a lot of opportunity to chase it.

What we don't spend a lot of time on is that the bottom 90% of these health systems and large hospitals are fairly resource strapped. They don't have big teams. They don't have big budgets. And so when change happens, even if it's positive innovation change, they don't have a lot of opportunity to chase it.

So what we're seeing this year is we're two years into this AI surge where now we've got this ubiquitous everybody must do AI. Demand for tech is rising. We've got these policy uncertainty things that are being introduced, like potential costs from tariffs, potential revenue problems from Medicaid changes that have been promised but not yet enacted.

So what we're seeing this year is we're two years into this AI surge where now we've got this ubiquitous everybody must do AI. Demand for tech is rising. We've got these policy uncertainty things that are being introduced, like potential costs from tariffs, potential revenue problems from Medicaid changes that have been promised but not yet enacted.

And you find a lot of systems who have uncertain investments, not enough time to look at it, not enough people to go kind of investigate what I should be doing. And it's causing a little bit of paralysis, right? So that that's the health care provider side.

And you find a lot of systems who have uncertain investments, not enough time to look at it, not enough people to go kind of investigate what I should be doing. And it's causing a little bit of paralysis, right? So that that's the health care provider side.

What it's doing on the tech side is causing a ton of uncertainty for a lot of very innovative, very kind of mission driven or positive minded firms with these great innovations. And they're facing a market that's kind of taking a taking a pause, catching its breath, not really buying a lot very quickly. And it's going to cause a little bit of a bubble.

What it's doing on the tech side is causing a ton of uncertainty for a lot of very innovative, very kind of mission driven or positive minded firms with these great innovations. And they're facing a market that's kind of taking a taking a pause, catching its breath, not really buying a lot very quickly. And it's going to cause a little bit of a bubble.

There's a lot of companies with VC investment or outside investment that have expectations and milestones. And they're facing a pretty tough year as, you know, some of these firms have gone a little too fast. They've overinvested in tech for two years. Now they're sitting there with uncertainty in the market. They don't know what to do. So what we're tracking this year.

There's a lot of companies with VC investment or outside investment that have expectations and milestones. And they're facing a pretty tough year as, you know, some of these firms have gone a little too fast. They've overinvested in tech for two years. Now they're sitting there with uncertainty in the market. They don't know what to do. So what we're tracking this year.

What I'm spending a lot of time on is how are these innovative, smaller health tech firms going to navigate this uncertainty, especially when the health systems themselves may not be in a position to be much use or to be very advising in that context?

What I'm spending a lot of time on is how are these innovative, smaller health tech firms going to navigate this uncertainty, especially when the health systems themselves may not be in a position to be much use or to be very advising in that context?